J 2002

Risperidone in children and adolescents with conduct disorders

DRTÍLKOVÁ, Ivana, Pavel THEINER and Josef BLAŽEK

Basic information

Original name

Risperidone in children and adolescents with conduct disorders

Authors

DRTÍLKOVÁ, Ivana (203 Czech Republic, guarantor), Pavel THEINER (203 Czech Republic) and Josef BLAŽEK (203 Czech Republic)

Edition

European Neuropsychopharmacology, 2002, 0924-977X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.492

RIV identification code

RIV/00216224:14330/02:00007122

Organization unit

Faculty of Informatics

Keywords in English

risperidone; children; conduct disorders

Tags

Změněno: 31/5/2003 10:05, RNDr. JUDr. Vladimír Šmíd, CSc.

Abstract

V originále

We initiated a retrospective study in order to examine the safety, tolerability and efficacy of risperidone in children and adolscents with conduct disorders. The sample included 34 patinets, dosis of risperidone were 1,29mg/day in average. Risperidone appeared to be safe and effective in ameliorating symptoms of conduct disorders in this age group.

Links

NF6520, research and development project
Name: Klinické a molekulárně-biologické koreláty hyperkinetické poruchy v dětském věku
Investor: Ministry of Health of the CR, Clinical and molecular-biological correlates of attention deficit hyperactivity disorder in children